| Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies M Oladejo, Y Paterson, LM Wood Frontiers in immunology 12, 642316, 2021 | 49 | 2021 |
| Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines M Oladejo, W Paulishak, L Wood Seminars in Cancer Biology 88, 81-95, 2023 | 19 | 2023 |
| Interferon stimulated gene 15 (ISG15) in cancer: An update HM Nguyen, S Gaikwad, M Oladejo, MY Agrawal, SK Srivastava, L Wood Cancer Letters, 2023 | 9 | 2023 |
| Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma M Oladejo, HM Nguyen, A Silwal, B Reese, W Paulishak, MM Markiewski, ... Frontiers in Immunology 13, 1038807, 2022 | 9 | 2022 |
| A Listeria-based vaccine targeting ISG15 exerts anti-tumor efficacy in renal cell carcinoma HM Nguyen, M Oladejo, W Paulishak, LM Wood Cancer Immunology, Immunotherapy 72 (9), 2889-2903, 2023 | 8 | 2023 |
| Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple‑negative breast cancer: an impact on classification and treatment approaches HM Nguyen, W Paulishak, M Oladejo, LM Wood Breast Cancer, 2022 | 5 | 2022 |
| Targeting Ubiquitin-Like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer HM Nguyen, S Gaikwad, M Oladejo, W Paulishak, L Wood Cancers, 0 | 5* | |
| Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma M Oladejo, HM Nguyen, H Seah, A Datta, L Wood Cancer Immunology and Immunotherapy, 2022 | 4 | 2022 |
| CD105 in the progression and therapy of renal cell carcinoma M Oladejo, HM Nguyen, L Wood Cancer Letters, 216327, 2023 | 3 | 2023 |
| Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection TS Anderson, AL McCormick, EA Daugherity, M Oladejo, IF Okpalanwaka, ... Oncoimmunology 12 (1), 2260620, 2023 | 2 | 2023 |
| Listeria-based immunotherapy sculpts CD8+ T cell response in the tumor microenvironment to control renal cell carcinoma. M Oladejo, L Wood Journal for ImmunoTherapy of Cancer (JITC), 2022 | 2 | 2022 |
| Adjuvants in cutaneous vaccination: A comprehensive analysis M Oladejo, AO Tijani, A Puri, L Chablani Journal of Controlled Release 369, 475-492, 2024 | | 2024 |
| ‘Free’ ISG15 acts as an immunoadjuvant to enhance CD8+ T cell-mediated anti-tumor immunity M Oladejo, L Wood Cancer Research 83 (7_Supplement), 4429-4429, 2023 | | 2023 |
| Targeting Ubiquitin-Like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer. Cancers 2023, 15, 1237 HM Nguyen, S Gaikwad, M Oladejo, W Paulishak, LM Wood | | 2023 |
| Listeria monocytogenes-based vaccines to mediate targeted ablation of the tumor-associated vasculature in colorectal cancer TS Anderson, AL Wooster, M Oladejo, L Wood, D Lowe CANCER IMMUNOLOGY RESEARCH 10 (12), 2022 | | 2022 |
| Abstract A68: Listeria monocytogenes-based vaccines to mediate targeted ablation of the tumor-associated vasculature in colorectal cancer TS Anderson, AL Wooster, M Oladejo, L Wood, D Lowe Cancer Immunology Research 10 (12_Supplement), A68-A68, 2022 | | 2022 |
| Tumoral Endoglin (CD105) Regulates the Tumor Microenvironment, Tumorigenicity and Therapeutic Response in Renal Cell Carcinoma M Oladejo, L Wood Journal of Radiation Oncology,Biology, Physics 114 (3), e208, 2022 | | 2022 |
Hong-My NguyenPfizer Inc.在 pfizer.com 的电子邮件经过验证
